Basic information Description Source Background Safety Supplier Related

HUMAN MDC (CCL22)

Basic information Description Source Background Safety Supplier Related

HUMAN MDC (CCL22) Basic information

Product Name:
HUMAN MDC (CCL22)
Synonyms:
  • ANTI-ADAM11 (N-TERM) antibody produced in rabbit
  • HUMAN CCL22
  • HUMAN MDC
  • CHEMOKINE STCP-1
  • HUMAN MDC (CCL22)
  • HUMAN MDC (CCL22) CHEMICALLY SYNTHESIZED CHEMOKINE
  • HUMAN MACROPHAGE DERIVED CHEMOATTRACTANT
  • HUMAN MACROPHAGE-DERIVED CHEMOKINE
MW:
0
Mol File:
Mol File
More
Less

HUMAN MDC (CCL22) Chemical Properties

storage temp. 
−20°C
form 
lyophilized powder
More
Less

Safety Information

Hazard Codes 
T
Risk Statements 
23/24/25-36/37/38
Safety Statements 
26-36/37/39-45

MSDS

More
Less

HUMAN MDC (CCL22) Usage And Synthesis

Description

MDC Human Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain containing 69 amino acids and having a molecular mass of 8.1 kDa.
The MDC is purified by proprietary chromatographic techniques.

Source

Escherichia Coli

Background

MDC (CCL22) is a small cytokine that belongs to the CC chemokine family. CCL22 is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 16.
MDC shows chemotactic activity for natural killer cells, chronically activated T lymphocytes, monocytes and dendritic cells. On the other hand, MDC shows a mild activity for primary activated T lymphocytes and has no chemoattractant activity for neutrophils, eosinophils and resting T lymphocytes. MDC may also have a role in the trafficking of activated T lymphocytes to inflammatory sites and other aspects of activated T lymphocyte physiology. MDC interacts with cell surface chemokine receptors CCR4.
CCL22 is vastly expressed in macrophage and in monocyte-derived dendritic cells, and thymus. CCL22 is also found in the lymph node, appendix, activated monocytes, resting and activated macrophages. Lower expression of CCL22 can be seen in the lung and the spleen and very weak expression in the small intestine. In the lymph node CCL22 is expressed in a mature subset of Langerhans' cells (CD1a+ and CD83+).
Furthermore, CCL22 is expressed in atopic dermatitis, allergic contact dermatitis skin, and psoriasis, in both the epidermis and dermis. In addition, MDC has a role in hindering progression of lung cancer. Moreover, significantly higher CCL22 expression is linked to gastric cancer.

HUMAN MDC (CCL22)Supplier

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Wuhan Chemstan Biotechnology Co., Ltd.
Tel
027-65317797 15926423062
Email
422450190@qq.com
Shanghai Yaji Biological Technology Co., Ltd.
Tel
021-34661275 15301693058
Email
yajikit@163.com
Shanghai Huzhen Industrial Co., LTD
Tel
021-60345367 13916550749
Email
sales@shzbio.com
Biolab Reagents
Tel
027-65279366 18108604356
Email
products@biolabreagent.com